Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Low TSH levels are not associated with osteoporosis in childhood.

Papadimitriou A, Papadimitriou DT, Papadopoulou A, Nicolaidou P, Fretzayas A.

Eur J Endocrinol. 2007 Aug;157(2):221-3.

PMID:
17656602
2.

Bone mineral density changes and bone turnover in thyroid carcinoma patients treated with supraphysiologic doses of thyroxine.

Karner I, Hrgović Z, Sijanović S, Buković D, Klobucar A, Usadel KH, Fassbender WJ.

Eur J Med Res. 2005 Nov 16;10(11):480-8.

PMID:
16354602
3.

Bone density and metabolism in subjects with microdeletion of chromosome 22q11 (del22q11).

Stagi S, Lapi E, Gambineri E, Manoni C, Genuardi M, Colarusso G, Conti C, Chiarelli F, de Martino M, Azzari C.

Eur J Endocrinol. 2010 Aug;163(2):329-37. doi: 10.1530/EJE-10-0167. Epub 2010 Jun 1.

PMID:
20516202
4.

[Bone density and laboratory parameters of bone metabolism in patients with terminal heart disease].

Christ E, Linka A, Junga G, Odermatt M, Steinert H, Kiowski W, Schmid C.

Schweiz Med Wochenschr. 1996 Sep 14;126(37):1553-9. German.

PMID:
8927958
5.

Persistent increase in bone turnover in Graves' patients with subclinical hyperthyroidism.

Kumeda Y, Inaba M, Tahara H, Kurioka Y, Ishikawa T, Morii H, Nishizawa Y.

J Clin Endocrinol Metab. 2000 Nov;85(11):4157-61.

PMID:
11095447
6.

Effects of oral alendronate in elderly patients with osteoporosis and mild primary hyperparathyroidism.

Rossini M, Gatti D, Isaia G, Sartori L, Braga V, Adami S.

J Bone Miner Res. 2001 Jan;16(1):113-9.

7.

BONE MINERAL DENSITY IN CHILDREN WITH IDIOPATHIC HYPERCALCIURIA.

Artemiuk I, Pańczyk-Tomaszewska M, Adamczuk D, Przedlacki J, Roszkowska-Blaim M.

Dev Period Med. 2015 Jul-Sep;19(3 Pt 2):356-61.

8.

Changes in bone mineral density and bone metabolism markers in premenopausal women with multiple sclerosis and the relationship to clinical variables.

Terzi T, Terzi M, Tander B, Cantürk F, Onar M.

J Clin Neurosci. 2010 Oct;17(10):1260-4. doi: 10.1016/j.jocn.2010.01.044. Epub 2010 Jul 8.

PMID:
20619660
9.

Thyroid hormone independent associations between serum TSH levels and indicators of bone turnover in cured patients with differentiated thyroid carcinoma.

Heemstra KA, van der Deure WM, Peeters RP, Hamdy NA, Stokkel MP, Corssmit EP, Romijn JA, Visser TJ, Smit JW.

Eur J Endocrinol. 2008 Jul;159(1):69-76. doi: 10.1530/EJE-08-0038. Epub 2008 Apr 7.

PMID:
18390987
10.

Calcidiol and PTH levels in women attending an osteoporosis program.

Haden ST, Fuleihan GE, Angell JE, Cotran NM, LeBoff MS.

Calcif Tissue Int. 1999 Apr;64(4):275-9.

PMID:
10089217
11.

Relationships among the metabolic syndrome, bone mineral density, bone turnover markers, and hyperglycemia.

Terzi R, Dindar S, Terzi H, Demirtaş Ö.

Metab Syndr Relat Disord. 2015 Mar;13(2):78-83. doi: 10.1089/met.2014.0074. Epub 2014 Dec 3.

PMID:
25470355
12.

A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial.

Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T.

J Clin Endocrinol Metab. 2001 Mar;86(3):1212-21. Erratum in: J Clin Endocrinol Metab 2001 Jul;86(7):3008.

PMID:
11238511
13.

A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre.

De Rosa G, Testa A, Maussier ML, Callà C, Astazi P, Albanese C.

Horm Metab Res. 1995 Nov;27(11):503-7.

PMID:
8770627
14.
15.

Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients.

Langdahl BL, Loft AG, Eriksen EF, Mosekilde L, Charles P.

Thyroid. 1996 Jun;6(3):169-75.

PMID:
8837322
16.

Skeletal involvement in female acromegalic subjects: the effects of growth hormone excess in amenorrheal and menstruating patients.

Scillitani A, Chiodini I, Carnevale V, Giannatempo GM, Frusciante V, Villella M, Pileri M, Guglielmi G, Di Giorgio A, Modoni S, Fusilli S, Di Cerbo A, Liuzzi A.

J Bone Miner Res. 1997 Oct;12(10):1729-36.

17.

Effect of TSH-suppressive doses of levothyroxine on bone mineral density in Thai women.

Ongphiphadhanakul B, Puavilai G, Rajatanavin R.

J Med Assoc Thai. 1996 Sep;79(9):563-7.

PMID:
8996984
18.

Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.

Marcocci C, Golia F, Bruno-Bossio G, Vignali E, Pinchera A.

J Clin Endocrinol Metab. 1994 Apr;78(4):818-23.

PMID:
8157704
19.

Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.

Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.

J Bone Miner Res. 1994 May;9(5):631-7.

PMID:
8053391
20.

Thyroid-stimulating hormone restores bone volume, microarchitecture, and strength in aged ovariectomized rats.

Sampath TK, Simic P, Sendak R, Draca N, Bowe AE, O'Brien S, Schiavi SC, McPherson JM, Vukicevic S.

J Bone Miner Res. 2007 Jun;22(6):849-59.

Supplemental Content

Support Center